Our data demonstrate that this kind of MUC1 peptide displacement/insertion in the CTB pentamer can induce MUC1-specific CTLs result in MUC1+ B16 tumor protective efficacy and therapeutic efficacy. The gene discussed is MUC1; the disease is neoplasm.